Veradigm (NASDAQ:MDRX) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX) in a report issued on Wednesday morning. The brokerage issued a hold rating on the software maker’s stock.

Veradigm Stock Up 0.5 %

MDRX stock opened at $9.05 on Wednesday. The firm’s fifty day moving average is $9.58 and its 200 day moving average is $9.07. Veradigm has a 52 week low of $5.01 and a 52 week high of $13.69.

Hedge Funds Weigh In On Veradigm

A number of large investors have recently bought and sold shares of the stock. Innealta Capital LLC bought a new position in shares of Veradigm in the second quarter worth approximately $38,000. Meadow Creek Wealth Advisors LLC bought a new position in shares of Veradigm in the first quarter worth approximately $83,000. Vanguard Group Inc. grew its holdings in shares of Veradigm by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after purchasing an additional 95,291 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Veradigm by 6.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock worth $16,749,000 after purchasing an additional 99,528 shares during the last quarter. Finally, Tyro Capital Management LLC bought a new position in shares of Veradigm in the first quarter worth approximately $9,055,000.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.